Form 8-K - Current report:
SEC Accession No. 0000950170-23-025091
Filing Date
2023-05-31
Accepted
2023-05-31 07:31:21
Documents
13
Period of Report
2023-05-31
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dtil-20230531.htm   iXBRL 8-K 87550
2 EX-99.1 dtil-ex99_1.htm EX-99.1 40698
  Complete submission text file 0000950170-23-025091.txt   264604

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dtil-20230531_lab.xml EX-101.LAB 13904
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dtil-20230531_pre.xml EX-101.PRE 10246
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dtil-20230531.xsd EX-101.SCH 2493
7 EXTRACTED XBRL INSTANCE DOCUMENT dtil-20230531_htm.xml XML 4896
Mailing Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701
Business Address 302 EAST PETTIGREW STREET SUITE A-100 DURHAM NC 27701 919-314-5512
PRECISION BIOSCIENCES INC (Filer) CIK: 0001357874 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38841 | Film No.: 23978935
SIC: 2836 Biological Products, (No Diagnostic Substances)